Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Achieve Life Sciences Inc (ACHV)

Achieve Life Sciences Inc (ACHV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Achieve Life Sciences Inc 1040 WEST GEORGIA STREET SUITE 1030 VANCOUVER BC V6E 4H1 CAN

www.achievelifesciences.com P: 604-210-2217

Description:

Achieve Life Sciences Inc. is a pharmaceutical company. It develops and commercializes cytisine treatment to help people battling nicotine addiction. The Company's product candidates include Custirsen, Apatorsen and OGX-225. Achieve Life Sciences Inc., formerly known as OncoGenex Pharmaceuticals Inc., is based in Bothell, United States.

Key Statistics

Overview:

Market Capitalization, $K 156,703
Enterprise Value, $K 157,893
Shares Outstanding, K 34,252
Annual Sales, $ 0 K
Annual Net Income, $ -29,820 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -5,480 K
EBIT, $ -27,250 K
EBITDA, $ -27,020 K
60-Month Beta 1.32
% of Insider Shareholders 2.00%
% of Institutional Shareholders 33.52%
Float, K 33,567
% Float 98.00%
Short Volume Ratio 0.40

Growth:

1-Year Return -42.96%
3-Year Return -57.60%
5-Year Return -94.70%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 03/28/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -1.53
EPS Growth vs. Prev Qtr 23.53%
EPS Growth vs. Prev Year 68.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 07/31/20

ACHV Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -936.69%
Return-on-Assets % -127.66%
Profit Margin % 0.00%
Debt/Equity -11.54
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.07
Interest Coverage -9.46
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar